ADHD treatment co Alcobra raises $26m on Nasdaq – Globes
Globes |
ADHD treatment co Alcobra raises m on Nasdaq
Globes Alcobra Pharmaceuticals Ltd. (Nasdaq: ADHD), which is developing a drug for treatment of attention deficit hyperactivity disorder (ADHD), raised million last Friday in a Nasdaq offering. The offering was at a share price, a 5% discount on the … |
